Skip to content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

AAOA Member Benefits

  • Up to 60% discount for CME programs and free Annual Meeting. All AAOA’s CME programs meet ABOTOHNS Continuing Certification.
  • AAOA US ENT Affinity program, where AAOA members can gain savings on antigen, allergy supplies, and any of the other 5 service lines US ENT offers. For more email info@usentpartners.com.
  • Tools and resources to comply with US General Chapter 797 and practice management tools.
  • Advocacy support.
  • And much more! Learn More

ADVOCACY UPDATES

Upcoming Dates

04/01/24: Fellow Exam Application Deadline
Learn more

06/01/24: Research Grant Cycle
Learn more

06/25/24: Membership Application Deadline to be eligible for AAOA Member rate for the 2024 Basic Course

08/02/24: Scientific Abstract Submission Deadline
Learn more

12/01/24: Research Grant Cycle
Learn more

EDUCATION

AAOA Advanced Course

The recorded course content is available until April 30, 2024. This year’s Advanced Course featured Laryngology and Skull Base Surgery with Nausheen Jamal, MD and Garret Choby, MD as featured faculty.

RESIDENTS

For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2024 AAOA Advanced Course in Allergy & Immunology - Hybrid
On-Demand Content Access Deadline:
April 30, 2024
Learn More and Register

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Register

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More 

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - April 1, 2024

News and Updates

New Orleans: Should I Stay or Should I Go?

Much like the Clash song lyrics, many of you will flip through this AAOA Today…

Read more

International Forum of Allergy & Rhinology Top Articles 2018-2019

Read top articles published in the International Forum of Allergy & Rhinology 2018-2019. Most Cited International Consensus…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

AAOA Logo

AAOA Partner Edge Pharma Resource Page

AAOA Partner: EdgePharma

EDGE Pharma Logo

Edge Pharma produces innovative pharmaceutical products for hospitals, surgery centers, and clinics across 16 specialties. Founded in 2013, Edge Pharma has grown to be one of the leading 503B Outsourcing suppliers in the United States. The unique nature of our business, both in terms of product breadth and knowledge base, makes us a great partner for every medical institution.

Our Focus on ENT and Allergy

Edge Pharmaceuticals, LLC is based in Coral Springs, Florida. We provide prescription medications, devices, and supplies to hospitals, health systems, Integrated Delivery Networks, surgery centers, and physician offices.

Edge operates securely in full compliance with all regulatory requirements. The Edge quality team ensures that every order is filled and delivered quickly and accurately. Customers are given access to traceability documentation for client confidence and full accountability.

  • We maintain strong relationships with manu­facturers, which translates into reliable supply and great pricing for our customers.
  • Strong focus on compounded ENT & Allergy products
  • Patient Specific allergy treatment vials
  • Compounded ENT products include nasal solutions, dexamethasone injection, and CSF Otic insufflation powder
  • No patient names required to order

Contact EdgePharma

Explore our Products below:

Our Products and Resources

Nasal Solution Image

Nasal Solutions

EDGE Pharma offers a variety nasal solutions for office use.

Patient specific allergy treatment vials: As an integral com­ponent of a complete lmmunotherapy solution, EDGE provides the outsourcing option for clinics that decide not to compound immunotherapy treatment sets in-house.

CSF Otic Image

CSF Otic Powder

CSF powder capsules from EDGE are avail­able in #4 sized capsules which are compatible with the most commonly used Sheehy-House lnsufflator.

Each capsule lasts for approximately 10-15 puffs.

Lab Image

Dexamethasone Injection

EDGE Pharma offers 24 mg/ml Dexamethasone for intratympanic Injection supplied in a 1 ml syringe.

Explore the Product Spotlight below.

Product Spotlight

Dexamethasone Injection Image

Intratympanic Dexamethasone Injection

Edge Pharma offers 24 mg/mL Dexamethasone for intratympanic Injection supplied in a 1 mL syringe.

  • Concentration = 24 mg/mL
  • Syringe Volume = 0.8 mL in a 1 mL syringe
  • Refrigerated storage
  • 90 day BUD

See Also:
Dexamethasone Iontophoresis Solution

EdgePharma Resources

EdgePharma offers the following resources to the AAOA Community:

Edge Pharma is an FDA-registered and state-licensed, 503B Outsourcing Facility providing service to hospital pharmacies, outpatient surgery Centers, and clinics. We offer USP 795 Nonsterile, USP 797 Sterile, and USP 800 Hazardous compounded medications. Edge also produces GMP material for clinical drug trials.

More to Come…………

AAOA Disclaimer

AAOA offers an opportunity for companies in the ENT-Allergy Community and Industry to bring relevant products, information and resources to its members.

 

AAOA holds no legal liability or responsibility for the products, services or information provided by participating companies.

 

If your company is interested in becoming a part of the AAOA Partner Resource Center, please call (202) 955-5010 or email Contact@aaoallergy.org.

Spotlight/News

Recent News

Nasal Sprays

Nasal Sprays can be an effective treatment options for many allergy sufferers. Read More

Allergy Testing

Allergy Testing is important to identify the allergens that impact you.
Read More

Recent Blog Articles

OrchardGrass

Useful Links

Back To Top